SELVAS Healthcare, Inc.

A208370

KR7208370007

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-22 EDT			5-day change	1st Jan Change
4,675 ^KRW	+0.32%		-5.46%	-31.55%

02-05	UltraSight Partners with SELVAS Healthcare to Develop and Commercialize AI-Powered Cardiac Ultrasound Software in Asia	CI
01-10	MEDIANA Co.,Ltd announced that it has received KRW 16.78452058 billion in funding from Selvas AI Inc., SELVAS Healthcare, Inc. and other investors	CI

Hana Must Second Special Purpose Acquisition Company Ltd. announced that it has received KRW 6.76 billion in funding from Timefolio Co.,Ltd. and other investors

November 29, 2015

On November 30, 2015, Hana Must Second Special Purpose Acquisition Company Ltd. (KOSDAQ:A208370) closed the transaction.

Latest news about SELVAS Healthcare, Inc.

UltraSight Partners with SELVAS Healthcare to Develop and Commercialize AI-Powered Cardiac Ultrasound Software in Asia	02-05	CI
MEDIANA Co.,Ltd announced that it has received KRW 16.78452058 billion in funding from Selvas AI Inc., SELVAS Healthcare, Inc. and other investors	01-09	CI
MEDIANA Co.,Ltd announced that it expects to receive KRW 23.78451844 billion in funding from Selvas AI Inc., SELVAS Healthcare, Inc. and other investors	11-19	CI
SELVAS Healthcare, Inc. agreed to acquire a 2.72% stake in Ultrasight Ltd. for KRW 1.4 billion.	23-06-11	CI
SELVAS Healthcare, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-14	CI
Selvas Healthcare Plans 34.1 Billion Won Share Sale	23-04-09	MT
SELVAS Healthcare, Inc. announced that it has received KRW 6 billion in funding from Ozoo I&A Co., Ltd.	21-07-07	CI
Selvas AI Inc. cancelled the acquisition of additional 15.3% in SELVAS Healthcare, Inc..	20-12-10	CI
Selvas AI Inc. agreed to acquire additional 15.3% in SELVAS Healthcare, Inc. for KRW 4.5 billion.	19-12-10	CI
SELVAS Healthcare, Inc. announced that it has received KRW 1.999998792 billion in funding from Selvas AI Inc.	19-04-18	CI
SELVAS Healthcare, Inc. announced that it expects to receive KRW 1.999998792 billion in funding from Selvas AI Inc.	19-04-10	CI
Infraware, Inc. completed the acquisition of 8.67% stake in SELVAS Healthcare, Inc. from Selvas AI Inc..	18-04-29	CI
Infraware, Inc. agreed to acquire 8.67% stake in SELVAS Healthcare, Inc. from Selvas AI Inc. for KRW 9 billion.	18-04-26	CI
SELVAS Healthcare, Inc. announced that it has received KRW 6.999996945 billion in funding from Eum Private Equity, Industrial Bank of Korea, Investment Arm	18-04-26	CI
SELVAS Healthcare, Inc. announced that it expects to receive KRW 6.99 billion in funding from Eum Private Equity, Industrial Bank of Korea, Investment Arm	18-04-19	CI
Selvas Healthcare Inc Appoints Yoo Byung Tak as Chief Executive Officer	17-04-19	CI
Tranche Update on SELVAS Healthcare, Inc.'s Equity Buyback Plan announced on October 10, 2016.	17-04-06	CI
SELVAS Healthcare, Inc.'s Equity Buyback announced on October 10, 2016, has expired with 22,400 shares, representing 0.18% for KRW 79.08 million.	17-04-06	CI
SELVAS Healthcare, Inc. announces an Equity Buyback for KRW 1,000 million worth of its shares.	16-10-09	CI
SELVAS Healthcare, Inc. authorizes a Buyback Plan.	16-10-09	CI
Jawonmedical. Co. Ltd. completed the acquisition of Hana Must Second Special Purpose Acquisition Company Ltd. in a reverse merger transaction.	16-08-30	CI
Jawonmedical. Co. Ltd. agreed to acquire Hana Must Second Special Purpose Acquisition Company Ltd. in a reverse merger transaction.	16-03-30	CI
Hana Must Second Special Purpose Acquisition Company Ltd. announced that it has received KRW 6.76 billion in funding from Timefolio Co.,Ltd. and other investors	15-11-29	CI
Jawonmedical. Co. Ltd announced that it expects to receive KRW 6.76 billion in funding from Timefolio Co.,Ltd. and other investors	15-11-12	CI
HIMS International Corporation acquired Jawonmedical. Co. Ltd for KRW 22.6 million.	15-08-17	CI

Selvas Healthcare Inc is a Korea-based company principally engaged in the manufacture and sale of medical devices. The Company is engaged in the manufacture and sale of body composition measuring instruments, blood pressure monitors, braille information terminals and other digital healthcare products. In addition, the Company is engaged in the development and sale of healthcare software. The Company was established in 1993.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
SELVAS HEALTHCARE, INC.	-31.55%	87.81M
THERMO FISHER SCIENTIFIC	+10.22%	223B
DANAHER CORPORATION	+12.99%	194B
INTUITIVE SURGICAL, INC.	+18.09%	141B
BOSTON SCIENTIFIC CORPORATION	+28.66%	109B
SIEMENS HEALTHINEERS AG	+1.41%	64.85B
EDWARDS LIFESCIENCES CORPORATION	+14.70%	52.7B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+6.68%	51.77B
AGILENT TECHNOLOGIES, INC.	+8.29%	44.12B
GE HEALTHCARE TECHNOLOGIES INC.	+2.60%	36.21B

Other Advanced Medical Equipment & Technology

SELVAS Healthcare, Inc.

Equities

A208370

KR7208370007

Advanced Medical Equipment & Technology

Hana Must Second Special Purpose Acquisition Company Ltd. announced that it has received KRW 6.76 billion in funding from Timefolio Co.,Ltd. and other investors

Latest news about SELVAS Healthcare, Inc.

Chart SELVAS Healthcare, Inc.

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Other Advanced Medical Equipment & Technology